Physician profile
Hector Lopez
NPI 1346243847
$1,809.52
in general payments reported to CMS, 2019-2025
20 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $245 · 2021: $68.18 · 2022: $284 · 2023: $536 · 2024: $439 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,088.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,087.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $423.45 | 2019-2024 | Airsupra, Breztri, Farxiga |
| Abbott Laboratories | $376.75 | 2022-2024 | Freestyle Libre 3 |
| Lilly USA, LLC | $300.53 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.39 | 2022-2023 | |
| Glaxosmithkline, LLC. | $88.79 | 2021-2024 | Arexvy, Shingrix |
| Novo Nordisk INC | $81.00 | 2020-2025 | |
| Exact Sciences Corporation | $79.97 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Kowa Pharmaceuticals America, INC. | $57.97 | 2019-2022 | |
| Amgen INC. | $44.28 | 2023-2025 | Krystexxa, Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.75 | 2022-2023 | Xifaxan |
| Pfizer INC. | $31.67 | 2020-2023 | |
| Inspire Medical Systems, INC. | $26.40 | 2023 | Inspire |
| Biogen, INC. | $23.82 | 2023 | Spinraza |
| Corcept Therapeutics | $23.46 | 2020 | |
| Travere Therapeutics, INC. | $21.65 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $21.17 | 2022 | |
| Abbvie INC. | $18.87 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.22 | 2023 | |
| Fidia Pharma USA INC. | $14.18 | 2021 | |
| Allergan, INC. | $12.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hector Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.